Qualigen Therapeutics Extends Research Agreement with University of Louisville Research Foundation on RAS Program
March 15, 2022 09:15 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...